Dr. Ricaurte is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4940 Eastern Avenue
Baltimore, MD 21224Phone+1 410-550-5624Fax+1 410-550-7694
Education & Training
- Stanford Health Care-Sponsored Stanford UniversityResidency, Neurology, 1984 - 1987
- McGaw Medical Center of Northwestern UniversityInternship, Internal Medicine, 1983 - 1984
- Northwestern University The Feinberg School of MedicineClass of 1981
Certifications & Licensure
- MD State Medical License 1988 - 2025
- FL State Medical License 2015 - 2017
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013-2014
Publications & Presentations
PubMed
- 6 citationsPharmacokinetic and pharmacodynamic analysis of d-amphetamine in an attention task in rodents.Jonathan M. Slezak, Melanie Mueller, George A. Ricaurte, Jonathan L. Katz
Behavioural Pharmacology. 2018-09-01 - 36 citationsAcquisition of MDMA self-administration: pharmacokinetic factors and MDMA-induced serotonin release.Sarah Bradbury, Judith Bird, Joyce Colussi-Mas, Melanie Mueller, George A. Ricaurte
Addiction Biology. 2014-09-01 - 15 citationsMethylphenidate and impulsivity: a comparison of effects of methylphenidate enantiomers on delay discounting in ratsJonathan M. Slezak, George A. Ricaurte, Ronald J. Tallarida, Jonathan L. Katz
Psychopharmacology. 2014-01-01
Grant Support
- PET Studies Of Amphetamine Treatment Of ADHDNational Institute Of Mental Health2009–2012
- Studies Of Substituted Amphetamine NeurotoxicityNational Institute On Drug Abuse2005–2009
- ADHD Treatment &Amphetamine NeurotoxicityEunice Kennedy Shriver National Institute Of Child Health &Human Development2005–2007
- MDMA Neurotoxicity In Humans: Occurrence And ConsequencesNational Center For Research Resources2004–2007
- PET Studies Of Methamphtamine Neurotoxicity In HumansNational Center For Research Resources2004–2006
- PET Studies Of Humans Exposed To MDMA (ECSTASY)National Center For Research Resources2004–2006
- Methamphetamine Neurotoxicity In Nonhuman PrimatesNational Institute On Drug Abuse2002–2006
- MDMA Neurotoxicity In Humans: Occurence &ConsequencesNational Institute On Drug Abuse2002–2006
- MDMA Neurotoxicity In Nonhuman PrimatesNational Institute On Drug Abuse2002–2005
- Substituted Amphetamine NeurotoxicityNational Institute On Drug Abuse1999–2003
- Gene Expression And Methamphetamine NeurotoxicityNational Institute On Drug Abuse2000–2002
- Safety Assessment Of Fenfluramine &Phentermine In HumansNational Center For Research Resources1999–2002
- PET &Csf Studies Of Humans Exposed To MDMA (ECSTASY)National Center For Research Resources1999–2002
- MDMA Neurotoxicity In Humans-- Occurence &ConsequenceNational Center For Research Resources1997–2002
- Safety Assessment Of Fenfluramine/PhentermineNational Institute On Drug Abuse1997–2001
- PET Studies Of Methamphetamine Neurotoxicity On HumansNational Center For Research Resources2000
- PET &Csf Studies Of Humans Exposed To MDMANational Center For Research Resources2000
- Assessment Of Fenfluramine &Phentermine In HumansNational Center For Research Resources2000
- PET Studies Of Methamphetamine Neurotoxicity In HumansNational Institute On Drug Abuse1998–2000
- PET And CSF Studies Of Humans Exposed To MethylenedioxymethamphetamineNational Center For Research Resources1998–1999
- MDMA Neurotoxicity--Occurrence &ConsequencesNational Institute On Drug Abuse1996–1999
- NDMA Neurotoxicity--Permanent Or TransientNational Institute On Drug Abuse1995–1999
- MDMA Neurotoxicity: Preclinical And Clinical EvaluationNational Institute On Drug Abuse1996–1998
- PET And CSF Studies Of Humans Exposed To MethamphetamineNational Center For Research Resources1996–1997
- PET Imaging Serotonin Neurotoxicity With (11c)Mcn5652National Institute On Drug Abuse1995–1997
- PET Imaging DA Neurotoxicity With 11C Win-35,428National Institute On Drug Abuse1995–1996
- NDMA Neurotoxicity--Occurrence &ConsequencesNational Institute On Drug Abuse1995
- CNational Institute On Drug Abuse1994–1995
- PET Imaging DA Neurotoxicity With ?11c? Win-35,428National Institute On Drug Abuse1994
- MDMA Neurotoxicity In Humans--Occurrence And ConsequencesNational Center For Research Resources1993–1994
- N-Methylated Analogues Of MDMA &FenfluramineNational Institute On Drug Abuse1991–1993
- MDMA Neurotoxicity In Primate: Permanent Or Transient?National Institute On Drug Abuse1989–1993
- MDMA Neurotoxicity In Humans--Occurrance &ConsequencesNational Institute On Drug Abuse1989–1991
- NDMA Neurotoxicity In Humans--Occurrence And ConsequencesNational Center For Research Resources1990
Other Languages
- Spanish
External Links
- Johns Hopkins Physicianshttp://www.hopkinsmedicine.org/george-ricaurte
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: